Puma Biotechnology (PBYI) Leases (2019 - 2025)
Puma Biotechnology (PBYI) has disclosed Leases for 7 consecutive years, with $5.4 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Leases rose 17.34% year-over-year to $5.4 million, compared with a TTM value of $5.4 million through Dec 2025, up 17.34%, and an annual FY2025 reading of $5.4 million, up 17.34% over the prior year.
- Leases was $5.4 million for Q4 2025 at Puma Biotechnology, down from $6.1 million in the prior quarter.
- Across five years, Leases topped out at $15.8 million in Q1 2021 and bottomed at $2.8 million in Q2 2025.
- Average Leases over 5 years is $9.4 million, with a median of $9.2 million recorded in 2023.
- Peak annual rise in Leases hit 17.34% in 2025, while the deepest fall reached 54.61% in 2025.
- Year by year, Leases stood at $14.0 million in 2021, then fell by 18.94% to $11.4 million in 2022, then plummeted by 31.42% to $7.8 million in 2023, then crashed by 41.23% to $4.6 million in 2024, then grew by 17.34% to $5.4 million in 2025.
- Business Quant data shows Leases for PBYI at $5.4 million in Q4 2025, $6.1 million in Q3 2025, and $2.8 million in Q2 2025.